Breast Cancer Vaccine
DNA vaccine inhibits breast cancer in mice through induction of autoimmunity
Published in Clinical Oncology Week, April 4th, 2005
According to a study from Italy, "Plasmid DNA vectors encoding the full-length (VR1012/HER-2-FL) or only the extracellular and transmembrane domains (VR1012/HER-2-ECD-TM) of human (h) HER-2/neu protooncogene were used to vaccinate HER-2/neu transgenic mice (N202) engineered to overexpress the rat (r) neu protooncogene product (r-p185neu). Both the full-length and the deleted vaccines were significantly (p=0.0001 and p=0.06, respectively) more active than the empty-vector (VR1012/EV) in preventing and delaying HER-2/neu-driven...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Carcinogenesis
Multistage theory of carcinogenesis refined - Head and Neck Cancer
Dendritic cells mature in presence of tumor cells from head and neck cancer - Melanoma Vaccine
Melanoma-associated antigen mimotope inhibits melanoma cell growth - Oncology
Bone-specific metastatic phenotypes identified as clinically relevant - Smoking
Impact of dietary factors on cancer screening in Japan examined - Acute Leukemia
Liposomal amphotericin B safe and effective for fungal infection treatment - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
